Cargando…

Qualitative study of patients’ decision-making when accepting second-line treatment after failure of first-line chemotherapy

OBJECTIVE: Treatment failures in advanced lung cancer are frequent events affecting patients during or after first-line chemotherapy. International guidelines recommend second-line chemotherapy. However, around one half of patients who experience disease progression enter a systemic second-line ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pujol, Jean-Louis, Roch, Benoît, Roth, Caroline, Mérel, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969734/ https://www.ncbi.nlm.nih.gov/pubmed/29799879 http://dx.doi.org/10.1371/journal.pone.0197605

Ejemplares similares

Second-line treatment in renal cell carcinoma: clinical experience and decision making
por: Guadalupi, Valentina, et al.
Publicado: (2021)

Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure
por: Kobayashi, Noritoshi, et al.
Publicado: (2017)

Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial
por: Oostendorp, Linda J. M., et al.
Publicado: (2017)

Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment
por: Vashist, Yogesh, et al.
Publicado: (2022)

Second-line docetaxel-based chemotherapy after failure of fluorouracil-based first-line treatment for advanced esophageal squamous cell carcinoma
por: Song, Zhengbo, et al.
Publicado: (2014)

Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India
por: Gill, Naresh, et al.
Publicado: (2019)

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis
por: Möhring, Christian, et al.
Publicado: (2021)

Shared Decision Making for the Emergency Provider: Engaging Patients When Seconds Count
por: Kanzaria, Hemal K., et al.
Publicado: (2020)

First‐line nurse managers’ perceptions of the challenges involved in decision‐making when older patients’ wish to die
por: Holm, Anne Lise, et al.
Publicado: (2018)

Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer
por: Jeon, Eun Kyoung, et al.
Publicado: (2011)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
por: Khan, Samsuddin, et al.
Publicado: (2014)

Which second line treatments after ESA failure?
por: Park, Sophie, et al.
Publicado: (2017)

Determinants of acceptance of patients with heart failure and their informal caregivers regarding an interactive decision-making system: a qualitative study
por: Zippel-Schultz, Bettina, et al.
Publicado: (2021)

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
por: Garajová, Ingrid, et al.
Publicado: (2023)

Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided (125)I Seed Implantation vs. Second-Line Chemotherapy
por: Wang, Hao, et al.
Publicado: (2020)

Modified K‐line for Making Decisions Regarding the Surgical Approach in Patients with K‐line (‐) OPLL
por: Liu, Xizhe, et al.
Publicado: (2021)

Bright line or lottery? On significance and value in medical decision making
por: Mahlich, Jörg, et al.
Publicado: (2021)

Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy
por: Ruan, Hanguang, et al.
Publicado: (2017)

Second-Line Surgical Management After Midurethral Sling Failure
por: Kwon, Joonbeom, et al.
Publicado: (2021)

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis
por: Citterio, Chiara, et al.
Publicado: (2018)

Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
por: Yamamoto, Shun, et al.
Publicado: (2021)

Quantifying pediatric patient need for second- and third-line HIV treatment: A tool for decision-making in resource-limited settings
por: Mohammed, Perry, et al.
Publicado: (2019)

Second line molecular diagnosis for bovine tuberculosis to improve diagnostic schemes
por: Michelet, Lorraine, et al.
Publicado: (2018)

‘Holding the line’: a qualitative study of the role of evidence in early phase decision-making in the reconfiguration of stroke services in London
por: Fraser, Alec, et al.
Publicado: (2017)

Patient Experiences and Perspectives of Their Decision-Making to Accept Lung Transplantation Referral: A Qualitative Study
por: Chen, Mengjie, et al.
Publicado: (2023)

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
por: Catalano, V, et al.
Publicado: (2008)

Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma
por: Minchom, Anna, et al.
Publicado: (2010)

A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
por: Ji, Sang Hoon, et al.
Publicado: (2009)

Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma
por: Lu, Bin, et al.
Publicado: (2019)

Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer
por: Gränsmark, Emma, et al.
Publicado: (2020)

Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?
por: Azmy, A., et al.
Publicado: (2013)

Second‐line treatment options in advanced thymic carcinoma after failure of platinum‐based chemotherapy: A multicenter retrospective study
por: Wang, Yang, et al.
Publicado: (2022)

Nucleotide second messengers in bacterial decision making
por: Thompson, Catriona MA, et al.
Publicado: (2020)

Concerns and Challenges of Living Donors When Making Decisions on Organ Donation: A Qualitative Study
por: Bahador, Raziyeh Sadat, et al.
Publicado: (2022)

Operative shortening of the sling as a second-line treatment after TVT failure
por: Gibas, Artur, et al.
Publicado: (2011)

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
por: Musana, Hellen, et al.
Publicado: (2021)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC – a phase II trial
por: Babiak, A, et al.
Publicado: (2007)

A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
por: Mercalli, A, et al.
Publicado: (2007)

The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o1el9i461h4lshgedlj9rkhl28